|
1
|
Brat DJ, Scheithauer BW, Fuller GN and
Tihan T: Newly codified glial neoplasms of the 2007 WHO
classification of tumours of the central nervous system:
Angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain
Pathol. 17:319–324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Osoba D, Brada M, Prados MD and Yung WK:
Effect of disease burden on health-related quality of life in
patients with malignant gliomas. Neuro Oncol. 2:221–228. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paul SP, Perrow R and Webster MA: Brain
tumours in children: Reducing time to diagnosis. Emerg Nurse.
22:32–36; quiz 37. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pollack IF: Brain tumors in children. N
Engl J Med. 331:1500–1507. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Turner CD, Chordas CA, Liptak CC,
Rey-Casserly C, Delaney BL, Ullrich NJ, Goumnerova LC, Scott RM,
Begley HC, Fletcher WJ, et al: Medical, psychological, cognitive
and educational late-effects in pediatric low-grade glioma
survivors treated with surgery only. Pediatr Blood Cancer.
53:417–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reimers TS, Mortensen EL and Schmiegelow
K: Memory deficits in long-term survivors of childhood brain tumors
may primarily reflect general cognitive dysfunctions. Pediatr Blood
Cancer. 48:205–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Ct and Morris JR: Genes, genetics, and
epigenetics: A correspondence. Science. 293:1103–1105. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Portela A and Esteller M: Epigenetic
modifications and human disease. Nat Biotechnol. 28:1057–1068.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goll MG and Bestor TH: Eukaryotic cytosine
methyltransferases. Annu Rev Biochem. 74:481–514. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Herman JG, Latif F, Weng Y, Lerman MI,
Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, et al:
Silencing of the VHL tumor-suppressor gene by DNA methylation in
renal carcinoma. Proc Natl Acad Sci USA. 91:9700–9704. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Costello JF, Berger MS, Huang HS and
Cavenee WK: Silencing of p16/CDKN2 expression in human gliomas by
methylation and chromatin condensation. Cancer Res. 56:2405–2410.
1996.PubMed/NCBI
|
|
15
|
Skiriute D, Vaitkiene P, Saferis V,
Asmoniene V, Skauminas K, Deltuva VP and Tamasauskas A: MGMT,
GATA6, CD81, DR4, and CASP8 gene promoter methylation in
glioblastoma. BMC Cancer. 12:2182012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Buczkowicz P, Hoeman C, Rakopoulos P,
Pajovic S, Letourneau L, Dzamba M, Morrison A, Lewis P, Bouffet E,
Bartels U, et al: Genomic analysis of diffuse intrinsic pontine
gliomas identifies three molecular subgroups and recurrent
activating ACVR1 mutations. Nat Genet. 46:451–456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bolstad BM: preprocessCore: A collection
of pre-processing functions. R Package. Version 1.22.0. 2014.
|
|
18
|
Tekpli X, Landvik NE, Anmarkud KH, Skaug
V, Haugen A and Zienolddiny S: DNA methylation at promoter regions
of interleukin 1B, interleukin 6, and interleukin 8 in non-small
cell lung cancer. Cancer Immunol Immunother. 62:337–345. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spiegl-Kreinecker S, Pirker C, Filipits M,
Lötsch D, Buchroithner J, Pichler J, Silye R, Weis S, Micksche M,
Fischer J and Berger W: O6-Methylguanine DNA methyltransferase
protein expression in tumor cells predicts outcome of temozolomide
therapy in glioblastoma patients. Neuro Oncol. 12:28–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Véron A, Blein S and Cox DG: Genome-wide
association studies and the clinic: A focus on breast cancer.
Biomark Med. 8:287–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kleihues P and Sobin LH: World Health
Organization classification of tumors. Cancer. 88:28872000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Enz R: Metabotropic glutamate receptors
and interacting proteins: Evolving drug targets. Curr Drug Targets.
13:145–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
D'Onofrio M, Arcella A, Bruno V, Ngomba
RT, Battaglia G, Lombari V, Ragona G, Calogero A and Nicoletti F:
Pharmacological blockade of mGlu2/3 metabotropic glutamate
receptors reduces cell proliferation in cultured human glioma
cells. J Neurochem. 84:1288–1295. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arcella A, Carpinelli G, Battaglia G,
D'Onofrio M, Santoro F, Ngomba RT, Bruno V, Casolini P, Giangaspero
F and Nicoletti F: Pharmacological blockade of group II
metabotropic glutamate receptors reduces the growth of glioma cells
in vivo. Neuro Oncol. 7:236–245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schröder D, Rehbach C, Seyffarth C,
Neuenschwander M, Kries JV and Windhorst S: Identification of a new
membrane-permeable inhibitor against
inositol-1,4,5-trisphosphate-3-kinase A. Biochem Biophys Res
Commun. 439:228–234. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sonnet M, Claus R, Becker N, Zucknick M,
Petersen J, Lipka DB, Oakes CC, Andrulis M, Lier A, Milsom MD, et
al: Early aberrant DNA methylation events in a mouse model of acute
myeloid leukemia. Genome Med. 6:342014. View Article : Google Scholar : PubMed/NCBI
|
